By proceeding, you agree to our Terms of Use and Privacy Policy.
MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.
27-30 September 2022
THE LARGEST BIOPROCESSING EVENT FOR LEARNING HOW TO ACCELERATE PROMISING BIOLOGICS, CELL & GENE THERAPIES TOWARDS COMMERCIAL SUCCESS. Our scientific agenda features 7 conference tracks focused on improving efficiencies across all phases of biopharmac
Event Ended
Hybrid
Paid
Boston
11-13 October 2022
The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
Carlsbad
11-14 October 2022
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional advi
Scotland
Edinburgh
04-08 December 2022
THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS Brand New Session Themes for 2022: How to Develop an Antibody-based Drug from Discovery to IND? Adaptive Immune Receptor Repertoire Data Processi
San Diego
16-20 May 2023
The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professionals in gene and cell therapy. The meeting, which we've expanded to four full days in 2023, is the best place for people in the field to learn fr
Los Angeles
18-21 September 2023
The Largest Bioprocessing Event is an annual conference held at the Boston Convention and Exhibition Center, focusing on accelerating the development and commercial success of promising biologics, cell therapies, and gene therapies. The event brings
13-16 December 2023
The latest science and research on antibody engineering, design and selection diving into critical topics including Neurodegenerative Diseases, Tumor Microenvironment in Antibody Therapy, Antibody Immune Agonist, Bi-Specifics, ADCs, Protein-Based Deg